APOMIGREN

PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF CANCER AND OTHER DISEASES WHERE INHIBITION OF ANGIOGENESIS PROVIDES A THERAPEUTIC BENEFIT